姑息治疗：初级保健药师视角
Palliative Care: A Primary Care Pharmacist Perspective.
作者信息
Bognar Julia
机构信息
Priory Medical Group, York YO24 3WX, UK.
出版信息
Pharmacy (Basel). 2022 Jul 13;10(4):81. doi: 10.3390/pharmacy10040081.
Abstract
The overview approaches pharmacy practice in palliative care from a global viewpoint and aims to provide insight into front-line pharmacist-patient relationships by sharing case studies and personal experiences.
摘要
本综述从全球视角探讨姑息治疗中的药学实践，旨在通过分享案例研究和个人经验，深入了解一线药师与患者的关系。
相似文献
1
Palliative Care: A Primary Care Pharmacist Perspective.姑息治疗：初级保健药师视角
Pharmacy (Basel). 2022 Jul 13;10(4):81. doi: 10.3390/pharmacy10040081.
2
Clinical networks influencing policy and practice: the establishment of advanced practice pharmacist roles for specialist palliative care services in South Australia.影响政策与实践的临床网络：南澳大利亚州专科姑息治疗服务中高级执业药师角色的设立
Aust Health Rev. 2014 May;38(2):238-41. doi: 10.1071/AH13030.
3
A nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan.一项关于日本医院药剂师干预措施以改善姑息治疗中癌症患者多重用药情况的全国性调查。
J Pharm Health Care Sci. 2019 Jul 3;5:14. doi: 10.1186/s40780-019-0143-5. eCollection 2019.
4
Retrospective analysis of a pilot pharmacist-led hospice deprescribing program initiative.回顾性分析一项由药剂师主导的临终关怀药物减量计划。
J Am Geriatr Soc. 2021 May;69(5):1370-1376. doi: 10.1111/jgs.17122. Epub 2021 Mar 26.
5
A pharmacist-led pilot program to facilitate deprescribing in a primary care clinic.药剂师主导的试点计划，以促进在初级保健诊所中进行减药。
J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):105-111. doi: 10.1016/j.japh.2019.09.011. Epub 2019 Nov 2.
6
Can a practice pharmacist improve prescribing safety and reduce costs in polypharmacy patients? A pilot study of an intervention in an Irish general practice setting.执业药师能否提高多药治疗患者的处方安全性并降低成本？爱尔兰一般实践环境中的干预措施的初步研究。
BMJ Open. 2022 May 27;12(5):e050261. doi: 10.1136/bmjopen-2021-050261.
7
Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.药剂师主导的减药干预对养老院居民的影响：一项随机对照试验。
Int J Clin Pharm. 2020 Aug;42(4):1153-1167. doi: 10.1007/s11096-020-01073-6. Epub 2020 Jun 3.
8
Polypharmacy in Palliative Care: Two Deprescribing Tools Compared with a Clinical Review.姑息治疗中的多药治疗：两种减药工具与临床审查的比较。
J Palliat Med. 2021 May;24(5):661-667. doi: 10.1089/jpm.2020.0225. Epub 2020 Sep 29.
9
Development of a required longitudinal residency experience focused on deprescribing.制定一项以减少药物治疗为重点的必需纵向住院医师培训经验。
Am J Health Syst Pharm. 2019 Feb 1;76(4):236-241. doi: 10.1093/ajhp/zxy029.
10
Development of an ambulatory palliative care pharmacist practice.门诊姑息治疗药剂师实践的发展
J Palliat Med. 2008 Oct;11(8):1077-82. doi: 10.1089/jpm.2008.0023.
引用本文的文献
1
Pharmacists are initiators in palliative care for patients with rare diseases.药剂师是罕见病患者姑息治疗的发起者。
Orphanet J Rare Dis. 2023 Jun 8;18(1):141. doi: 10.1186/s13023-023-02765-8.
本文引用的文献
1
Meeting ethical challenges with authenticity when engaging patients and families in end-of-life and palliative care research: a qualitative study.在终末期和姑息治疗研究中与患者及其家属接触时保持真实性以应对伦理挑战：一项定性研究。
BMC Palliat Care. 2022 May 16;21(1):74. doi: 10.1186/s12904-022-00964-x.
2
Developing a meta-understanding of 'human aspects' of providing palliative care.对提供姑息治疗的“人文因素”形成一种元理解。
Palliat Care Soc Pract. 2022 Mar 9;16:26323524221083679. doi: 10.1177/26323524221083679. eCollection 2022.
3
Understanding the Potential for Pharmacy Expertise in Palliative Care: The Value of Stakeholder Engagement in a Theoretically Driven Mapping Process for Research.了解药学专业知识在姑息治疗中的潜力：利益相关者参与理论驱动的研究映射过程的价值。
Pharmacy (Basel). 2021 Nov 26;9(4):192. doi: 10.3390/pharmacy9040192.
4
Building Strong Clinician-Researcher Collaborations for Successful Hospice and Palliative Care Research.建立强大的临床医生-研究人员合作关系，以促进临终关怀和姑息治疗研究的成功。
J Hosp Palliat Nurs. 2022 Feb 1;24(1):64-69. doi: 10.1097/NJH.0000000000000818.
5
Managing medicines at the end of life: a position paper for health policy and practice.生命末期的药品管理：卫生政策和实践的立场文件。
J Health Organ Manag. 2021 Nov 18;35(9):368-377. doi: 10.1108/JHOM-11-2020-0440.
6
Polypharmacy in Palliative Care for Advanced Heart Failure: The PAL-HF Experience.晚期心力衰竭姑息治疗中的多药治疗：PAL-HF 经验。
J Card Fail. 2022 Feb;28(2):334-338. doi: 10.1016/j.cardfail.2021.08.021. Epub 2021 Oct 7.
7
Primary care service use by end-of-life cancer patients: a nationwide population-based cohort study in the United Kingdom.终末期癌症患者的初级保健服务利用：英国全国范围内基于人群的队列研究。
BMC Fam Pract. 2020 Apr 29;21(1):76. doi: 10.1186/s12875-020-01127-8.
8
Challenges in Palliative Care Research on Family Caregivers: Who Volunteers for Interviews?姑息治疗中家庭照顾者研究面临的挑战：谁会自愿接受访谈？
J Palliat Med. 2021 Jan;24(1):112-115. doi: 10.1089/jpm.2019.0672. Epub 2020 Apr 7.
9
Primary palliative care research: opportunities and challenges.初级姑息治疗研究：机遇与挑战。
BMJ Support Palliat Care. 2019 Dec;9(4):468-472. doi: 10.1136/bmjspcare-2018-001653. Epub 2019 Feb 12.
10
Medication management for community palliative care patients and the role of a specialist palliative care pharmacist: A qualitative exploration of consumer and health care professional perspectives.社区姑息治疗患者的药物管理和专科姑息治疗药剂师的作用：消费者和医疗保健专业人员观点的定性探讨。
Palliat Med. 2018 Sep;32(8):1369-1377. doi: 10.1177/0269216318777390. Epub 2018 May 25.
Zotero 插件